Dasatinib

Nat Rev Drug Discov. 2006 Sep;5(9):717-8. doi: 10.1038/nrd2135.
No abstract available

Publication types

  • News

MeSH terms

  • Administration, Oral
  • Adult
  • Clinical Trials as Topic
  • Dasatinib
  • Drug Approval / methods
  • Guideline Adherence / standards
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Molecular Structure
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / administration & dosage
  • Pyrimidines / chemistry
  • Pyrimidines / therapeutic use*
  • Thiazoles / administration & dosage
  • Thiazoles / chemistry
  • Thiazoles / therapeutic use*
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib